North America Soft Tissue Repair Market – Industry Trends and Forecast to 2029

Market Analysis and Size

Soft tissues such as tendons, muscles, fascia, nerves, fat, ligaments, blood vessels, and synovial membranes connect, surround, and support other body structures and organs.. Many physical activities can cause them to get damaged, leading to pain, sprains, strains, edema, bursitis, tendinitis, and contusions. As a result, a variety of therapeutic methods for restoring, repairing, and regenerating soft tissues are used. Scaffolds consisting of natural polymers like as chitosan, gelatin, and alginate, for example, are employed as biomaterials for their restoration. Aside from that, the use of allografts and xenografts for treating severe damage is gaining popularity around the world.

Data Bridge Market Research analyses that the soft tissue repair market which was USD 3,806.87 million in 2021, would rocket up to USD 6540.91 million by 2029, and is expected to undergo a CAGR of 7.0% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Soft tissue repair is a medical process that is used to heal soft tissue injuries like sprains, strains, and other issues. In most cases, soft tissue injuries result in intense pain and a loss of function. Soft tissue is a very competitive market. Soft tissue repair product vendors invest a large portion of their money in new product R&D to obtain a competitive advantage and position their goods distinctively in the global market. As a result, several new and sophisticated devices have been introduced that use novel and modern materials to improve surgical care and healing.

Report Scope and Market Segmentation

Soft Tissue Repair Market Dynamics

Drivers

• Laparoscopic procedures are widely conducted with biological materials

They have a number of benefits over their traditional equivalents. Improvements in payment programmes and insurance policies are crucial in growing demand for soft tissue repair devices in this area. As a result, these factors are expected to drive market expansion in North America during the next several years.

• New developments and technologies

Vendors can increase their reach in emerging markets and acquire new clients. This aspect is projected to drive the soft tissue repair market in North America. New product releases by North American and local companies and technological advancements in regenerative medicine are expected to play a key role in the soft tissue repair market's future growth.

• Increasing participation of individuals

 The chance of having a soft tissue injury in professional sports is higher. This, together with parents' growing concerns about their children's physical health, constitutes one of the key factors positively driving market growth. Its repair aids in quicker recuperation and enhanced sports performance.

• Increasing incidences of musculoskeletal disorders

The reorganization of the bone and its accompanying soft tissues necessitates the use of biomedical implants. Other factors, such as good reimbursement policies, the growing popularity of medical tourism, and increased investments in research and development (R&D), are expected to boost market expansion.

Opportunities

Soft tissue repair is in high demand in Canada, the rising prevalence of musculoskeletal illnesses, the ageing population, and an increase in sports-related and other accidents. This rising demand will aid the market's expansion in the next years. An growth in the life sciences industry's research and development capacity is one of the major reasons driving the market's progress. Increased awareness of the necessity of maintaining health and fitness, as well as an increase in the number of gyms and sports centres, are further market growth variables. Other major aspects that will provide profitable market growth potential include increased westernization and medical tourism.

Restraints/Challenges

In developing and underdeveloped economies, inappropriate and unfavourable reimbursement scenarios would impede industry expansion. Furthermore, the market would be challenged by the high expenses associated with research and development capabilities. In backward economies, skilled specialists' scarcity will hinder the market expansion.

However, substantial damages or tears to a soft tissue caused by accident, for example, or other circumstances may necessitate surgery, but the high expense of these surgical operations may stymie soft tissue repair growth.

This soft tissue repair market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the soft tissue repair market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Soft Tissue Repair Market

The COVID-19 outbreak significantly impacted all aspects of orthopedic care and practice. The outbreak pandemic has negatively affected activities related to the outpatient clinic, emergency and elective surgery, rehabilitation, resident training, personnel management, personal protective equipment use, telemedicine, and all sub-specialties of orthopedics. As a result, the crisis is stifling growth in the North American soft tissue repair sector. Because of the rising prevalence of COVID-19, hospitals have become high-risk environments, particularly for patients with chronic illnesses. As a result, non-critical treatments such as elective surgeries were cancelled or postponed throughout the first and second quarters of 2020, resulting in a considerable decrease in total elective surgical procedures conducted.

Recent Development

• In July 2021, Tepha, Inc., a prominent researcher and manufacturer of unique resorbable polymer technology, was acquired by B.D. Tepha's patented resorbable polymer, poly 4-hydroxybutyric acid (P4HB), provides significant innovation possibilities for B.D.'s surgical mesh portfolio, allowing it to expand into new areas of soft tissue repair, reconstruction, and regeneration.
• In April 2020, ClearGuard LE Endoscopic Soft Tissue Release System was created by In2Bones for orthopaedic and podiatric physicians in the United States to address a variety of foot ailments. The company is a creator, manufacturer, and distributor of medical devices for the treatment of illnesses and injuries situated in the United States. For high-volume lower extremity soft tissue procedures on the plantar fascia, gastrocnemius, tarsal tunnel, and Morton's neuroma, the ClearGuard LE Endoscopic Soft Tissue Release Solution provides an easy-to-use, reproducible, and cost-effective system for orthopaedic and podiatric physicians.

North America Soft Tissue Repair Market Scope

The soft tissue repair market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Fixation Products
  • Suture
  • Suture Anchors
• Tissue Patch/Match
  • Biological
  • Synthetic

Application

• Orthopedic Surgery
• Breast Reconstruction
• Hernia Repair
• Skin Repair
• Vaginal Sling Repair
• Cardiovascular Surgery
• Others

End-User:

• Hospitals and Clinics
• Research and Academic Institutes
• Others

Soft Tissue Repair Market Regional Analysis/Insights

The soft tissue repair market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.

The countries covered in the soft tissue repair market report are U.S., Canada and Mexico in North America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The soft tissue repair market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for soft tissue repair market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the soft tissue repair market. The data is available for historic period 2010-2020.

Competitive Landscape and Soft Tissue Repair Market Share Analysis

The soft tissue repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to soft tissue repair market.

Some of the major players operating in the soft tissue repair market are:

• BD (U.S)
• Boston Scientific Corporation (U.S)
• Stryker (U.S)
• Athersys Inc (U.S)
• Allergan (U.S)
• Terumo Corporation (Japan)
• Smith & Nephew Plc. (UK)
• Arthrex, Inc (US)
• Johnson & Johnson (US)
• Medtronic Plc. (Ireland)
• LifeNet Health, Inc. (US)
• Integra LifeSciences Corporation (US)
• CryoLife, Inc. (US)
• Organogenesis Inc. (US)
• Zimmer Biomet (US)
• Baxter International, Inc. (US)
• ACell Inc. (US)
• Tissue Regenix Group Plc (UK)
• Aroa Biosurgery Ltd. (U.S)

SKU-1794